← FDA DRUG APPROVALS
FDA ANDA · ANDA212408
ENALAPRIL MALEATE ORAL SOLUTION
enalapril maleate
Sponsor: BIONPHARMA
APPLICATION
ANDA212408
TYPE
ANDA
ORIGINAL APPROVAL
2021-08-10
LATEST ACTION
2021-08-10
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ENALAPRIL MALEATEPrescription
ENALAPRIL MALEATE 1MG/ML · SOLUTION · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.